Example: Heart Attack

Clinical Trials Sponsored by Angiochem Inc

Total 8 results





    • NCT03613181
      Not yet recruiting
      ANG1005 in Leptomeningeal Disease From Breast Cancer
      Conditions: Leptomeningeal Carcinomatosis; Leptomeningeal Metastases; Brain Metastases; HER2-negative Breast Cancer
    • NCT02755987
      No longer available
      Expanded Access to ANG1005 for Individual Patients
      Conditions: Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Breast Cancer With Recurrent Brain Metastases; Leptomeningeal Carcinomatosis
    • NCT02048059
      Completed
      ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
      Conditions: Breast Cancer; Brain Metastases
    • NCT01967810
      Completed
      ANG1005 in Patients With Recurrent High-Grade Glioma
      Conditions: Glioma; Glioblastoma; Brain Tumor, Recurrent
    • NCT01497665
      Terminated
      GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
      Conditions: Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
    • NCT01480583
      Completed
      GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
      Conditions: Breast Cancer; Brain Metastases
    • NCT00539344
      Completed
      A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
      Conditions: Recurrent or Progressive Malignant Glioma
    • NCT00539383
      Completed
      A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
      Conditions: Advanced Solid Tumors With and Without Brain Metastases
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations